As financing for emerging medical technologies becomes harder to come by, corporate investors have been growing more active, in many cases filling a void where adventuresome, early-stage investors used to be.
GE Healthymagination Sue Siegel, chief executive of GE Healthymagination. General Electric, which has several investing divisions, including a $250 million fund for backing new innovations for health care, is a case in point. GE Healthymagination, as the fund is known, is opening a new office among the venture firms of Sand Hill Road in Silicon Valley, hiring investors from top firms and putting money into play.
To read the original article: CORPORATE SPEAK: Why GE is Bullish on Medical Technology - Venture Capital Dispatch - WSJ
